Business Standard

Top headlines: India approves Moderna vaccine; Sebi announces reforms

Business Standard brings you the top news of the evening

Moderna vaccine
Premium

Photo: Shutterstock

BS Web Team New Delhi
India approves Moderna's vaccine for emergency use; Cipla to import jab

Drug major Cipla has been approved by India's drug regulator to import Moderna's coronavirus vaccine for restricted emergency use in the country, the government said on Tuesday. Moderna is said to have applied for the emergency use approval in India following the US agreement to donate doses to India via Covax. Cipla on behalf of the US pharma giant has requested for import and marketing authorisation of these jabs. READ MORE...
 
Sebi overhauls norms for appointment, removal of independent directors

The Securities and Exchange

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in